Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$13.43 - $19.16 $141,015 - $201,180
-10,500 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$15.82 - $22.11 $166,110 - $232,155
10,500 New
10,500 $172,000
Q4 2020

Feb 16, 2021

SELL
$7.91 - $22.95 $93,338 - $270,810
-11,800 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$7.36 - $9.87 $86,848 - $116,465
11,800 New
11,800 $90,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $668M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Js Capital Management LLC Portfolio

Follow Js Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Js Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Js Capital Management LLC with notifications on news.